BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29404749)

  • 21. Reduced protective efficacy of a blood-stage malaria vaccine by concurrent nematode infection.
    Su Z; Segura M; Stevenson MM
    Infect Immun; 2006 Apr; 74(4):2138-44. PubMed ID: 16552043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testosterone impairs efficacy of protective vaccination against P. chabaudi malaria.
    Wunderlich F; Maurin W; Benten WP; Schmitt-Wrede HP
    Vaccine; 1993; 11(11):1097-9. PubMed ID: 8249427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmodium chabaudi AS: distinct CD4(+)CD25(+)Foxp3(+) regulatory T cell responses during infection in DBA/2 and BALB/c mice.
    Wang GG; Chen G; Feng H; Liu J; Jiang YJ; Shang H; Cao YM
    Parasitol Int; 2013 Feb; 62(1):24-31. PubMed ID: 22971347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic miRNA expression reprogrammed by Plasmodium chabaudi malaria.
    Delić D; Dkhil M; Al-Quraishy S; Wunderlich F
    Parasitol Res; 2011 May; 108(5):1111-21. PubMed ID: 21085987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testosterone-induced permanent changes of hepatic gene expression in female mice sustained during Plasmodium chabaudi malaria infection.
    Delić D; Gailus N; Vohr HW; Dkhil M; Al-Quraishy S; Wunderlich F
    J Mol Endocrinol; 2010 Dec; 45(6):379-90. PubMed ID: 20844152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Organ-specific testosterone-insensitive response of miRNA expression of C57BL/6 mice to Plasmodium chabaudi malaria.
    Al-Quraishy S; Dkhil MA; Delic D; Abdel-Baki AA; Wunderlich F
    Parasitol Res; 2012 Sep; 111(3):1093-101. PubMed ID: 22562236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of an antibody that recognizes Plasmodium chabaudi cysteine protease (chabaupain-1) in both sexual and asexual parasite life cycle and evaluation of chabaupain-1 vaccine potential.
    Armada A; Gazarini ML; Gonçalves LM; Antunes S; Custódio A; Rodrigues A; Almeida AJ; Silveira H; Rosário Vd; Santos-Gomes G; Domingos A
    Exp Parasitol; 2013 Sep; 135(1):166-74. PubMed ID: 23830988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Up- and down-modulation of liver cytochrome P450 activities and associated events in two murine malaria models.
    De-Oliveira AC; Carvalho RS; Paixão FH; Tavares HS; Gueiros LS; Siqueira CM; Paumgartten FJ
    Malar J; 2010 Mar; 9():81. PubMed ID: 20307316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expansion of IL-3-responsive IL-4-producing non-B non-T cells correlates with anemia and IL-3 production in mice infected with blood-stage Plasmodium chabaudi malaria.
    Helmby H; Kullberg M; Troye-Blomberg M
    Eur J Immunol; 1998 Aug; 28(8):2559-70. PubMed ID: 9710233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deletion of LTbetaR augments male susceptibility to Plasmodium chabaudi.
    Krücken J; Braun JV; Dkhil MA; Grunwald A; Wunderlich F
    Parasite Immunol; 2005 Jun; 27(6):205-12. PubMed ID: 16048639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential induction of malaria liver pathology in mice infected with Plasmodium chabaudi AS or Plasmodium berghei NK65.
    Scaccabarozzi D; Deroost K; Corbett Y; Lays N; Corsetto P; Salè FO; Van den Steen PE; Taramelli D
    Malar J; 2018 Jan; 17(1):18. PubMed ID: 29316914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cryptic T cell epitope on the apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an anamnestic antibody response: implications for malaria vaccine design.
    Amante FH; Crewther PE; Anders RF; Good MF
    J Immunol; 1997 Dec; 159(11):5535-44. PubMed ID: 9548494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indigofera oblongifolia regulates the hepatic gene expression profile induced by blood stage malaria.
    Al-Shaebi EA; Dkhil MA; Al-Quraishy S
    Microb Pathog; 2018 Jun; 119():170-182. PubMed ID: 29630927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic cells induce immunity and long-lasting protection against blood-stage malaria despite an in vitro parasite-induced maturation defect.
    Pouniotis DS; Proudfoot O; Bogdanoska V; Apostolopoulos V; Fifis T; Plebanski M
    Infect Immun; 2004 Sep; 72(9):5331-9. PubMed ID: 15322030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In silico identification of genetically attenuated vaccine candidate genes for Plasmodium liver stage.
    Kumar H; Frischknecht F; Mair GR; Gomes J
    Infect Genet Evol; 2015 Dec; 36():72-81. PubMed ID: 26348884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo IL-12 production and IL-12 receptors beta1 and beta2 mRNA expression in the spleen are differentially up-regulated in resistant B6 and susceptible A/J mice during early blood-stage Plasmodium chabaudi AS malaria.
    Sam H; Stevenson MM
    J Immunol; 1999 Feb; 162(3):1582-9. PubMed ID: 9973416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ICAM-1 is a key receptor mediating cytoadherence and pathology in the Plasmodium chabaudi malaria model.
    Cunningham DA; Lin JW; Brugat T; Jarra W; Tumwine I; Kushinga G; Ramesar J; Franke-Fayard B; Langhorne J
    Malar J; 2017 May; 16(1):185. PubMed ID: 28468674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IFN-γ-induced priming maintains long-term strain-transcending immunity against blood-stage Plasmodium chabaudi malaria.
    da Silva HB; de Salles EM; Panatieri RH; Boscardin SB; Rodríguez-Málaga SM; Alvarez JM; D'Império Lima MR
    J Immunol; 2013 Nov; 191(10):5160-9. PubMed ID: 24133169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new approach to generate a safe double-attenuated Plasmodium liver stage vaccine.
    Nagel A; Prado M; Heitmann A; Tartz S; Jacobs T; Deschermeier C; Helm S; Stanway R; Heussler V
    Int J Parasitol; 2013 May; 43(6):503-14. PubMed ID: 23500072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
    Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
    J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.